Login to Your Account



Intercept's Climb for Diabetes Easier with $163M Alliance

By Mari Serebrov


Wednesday, August 10, 2011
Intercept Pharmaceuticals Inc. is looking to a $163 million collaboration agreement with Les Laboratoires Servier to help it scale the mountainous challenges involved in developing a novel diabetes drug.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription